Role for G12/G13 in agonist-induced vascular smooth muscle cell contraction

被引:191
|
作者
Gohla, A
Schultz, G
Offermanns, S
机构
[1] Univ Heidelberg, Inst Pharmakol, D-69120 Heidelberg, Germany
[2] Free Univ Berlin, Klinikum Benjamin Franklin, Inst Pharmakol, D-12200 Berlin, Germany
关键词
smooth muscle; vasocontractors; G proteins; Rho-kinase; myosin light chain phosphorylation;
D O I
10.1161/01.RES.87.3.221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Receptor-induced vascular smooth muscle cell contraction is mediated by dual regulation of myosin light chain (MLC20) phosphorylation through Ca2+-dependent stimulation of myosin light chain kinase and Rho/Rho-kinase-mediated inhibition of myosin phosphatase, Although myosin light chain kinase regulation is initiated by the coupling of receptors to G proteins of the G(q) family, G(q) and G(11), it is not known how receptors regulate the Rho/Rho-kinase-mediated pathway. In vascular smooth muscle cells, receptor-mediated MLC20 phosphorylation and cell contraction was blocked by inhibitors of each of the pathways. Receptors of various vasocontractors were found to couple to G(q)/G(11) and G(12)/G(13), and constitutively active forms of G alpha(12) and G alpha(13) induced a pronounced contraction of vascular smooth muscle cells that could be blocked by C3 exoenzyme, by inhibition of Rho-kinase, and by stable analogues of cGMP and cAMP. Receptor-mediated smooth muscle cell contraction was strongly inhibited by dominant-negative forms of G alpha(12) and G alpha(13). These data indicate that a G(12)/G(13)-mediated Rho/Rho-kinase-dependent pathway operates in smooth muscle cells and that dual regulation of MLC20 phosphorylation by vasocontractors is initiated by the dual coupling of their receptors to G proteins of the G(q) and G(12) families.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 27 条
  • [21] Modulation of large conductance Ca2+-activated K+ channel by Gαh (transglutaminase II) in the vascular smooth muscle cell
    Moo-Yeol Lee
    Sungkwon Chung
    Hyo-Weon Bang
    Kwang Jin Baek
    D.-Y. Uhm
    Pflügers Archiv, 1997, 433 : 671 - 673
  • [22] Modulation of large conductance Ca2+-activated K+ channel by G alpha(h) (transglutaminase II) in the vascular smooth muscle cell
    Lee, MY
    Chung, SK
    Bang, HW
    Baek, KJ
    Uhm, DY
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1997, 433 (05): : 671 - 673
  • [23] GAPDH Protects Vascular Smooth Muscle Cells Against Oxidant-Induced Cell Death: Potential Role in Prevention of Atherosclerotic Plaque Destabilization
    Sukhanov, Sergiy
    Yoshida, Tadashi
    Higashi, Yusuke
    Delafontaine, Jean-Luc
    Kim, Catherine
    Delafontaine, Patrick
    CIRCULATION, 2012, 126 (21)
  • [24] Mechanical stress-induced heat shock protein 70 expression in vascular smooth muscle cells is regulated by rac and ras small G proteins but not mitogen-activated protein kinases
    Xu, QB
    Schett, G
    Li, CH
    Hu, YH
    Wick, G
    CIRCULATION RESEARCH, 2000, 86 (11) : 1122 - 1128
  • [25] Cell-volume-dependent vascular smooth muscle contraction: role of Na+, K+, 2Cl− cotransport, intracellular Cl− and L-type Ca2+ channels
    Yana J. Anfinogenova
    Mikhail B. Baskakov
    Igor V. Kovalev
    Alexander A. Kilin
    Nickolai O. Dulin
    Sergei N. Orlov
    Pflügers Archiv, 2004, 449 : 42 - 55
  • [26] Cell-volume-dependent vascular smooth muscle contraction:: role of Na+, K+, 2Cl- cotransport, intracellular Cl- and L-type Ca2+ channels
    Anfinogenova, YJ
    Baskakov, MB
    Kovalev, IV
    Kilin, AA
    Dulin, NO
    Orlov, SN
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 449 (01): : 42 - 55
  • [27] Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells - Evidence for an obligate autocrine mechanism promoting cell proliferation induced by G protein-coupled receptor agonists
    Molloy, CJ
    Pawlowski, JE
    Taylor, DS
    Turner, CE
    Weber, H
    Peluso, M
    Seiler, SM
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (05): : 1173 - 1183